Transient Ischemic Attack clinical trials at UCLA
2 in progress, 1 open to eligible people
Showing trials for
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
open to eligible people ages 30 years and up
An observational study to determine if individuals with increased platelet FcyRIIa will have a higher risk of ischemic events.
Los Angeles, California
Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
Sorry, in progress, not accepting new patients
The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.
Torrance, California and other locations
Our lead scientists for Transient Ischemic Attack research studies include David Liebeskind, MD.
Last updated: